Ayurvedic formulations: Potential COVID-19 therapeutics?
Antivirals
Ayurvedic formulations
COVID-19
Clinical trials
In silico molecular docking
Journal
Phytomedicine plus : international journal of phytotherapy and phytopharmacology
ISSN: 2667-0313
Titre abrégé: Phytomed Plus
Pays: Netherlands
ID NLM: 9918382982506676
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
entrez:
27
4
2022
pubmed:
28
4
2022
medline:
28
4
2022
Statut:
ppublish
Résumé
While Molnupiravir and Paxlovid have recently been approved for use in some countries, there are no widely available treatments for COVID-19, the disease caused by SARS-CoV-2 infection. Herbal extracts have been used to treat respiratory clinical indications by Ayurvedic medicine practitioners with minimal adverse reactions and intense research efforts are currently under way to develop some of these formulations for COVID-19 treatment. Literature search for The search yielded 20 peer reviewed articles on The most commonly used Ayurvedic treatments for management of respiratory symptoms associated with SARS-CoV-2 infection appear to have prophylactic and/or therapeutic properties. It would be of particular interest to assess synergistic and concomitant systemic effects and antiviral activities of individual phytoconstituents and their combinations in the Ayurvedic treatments.
Sections du résumé
BACKGROUND
BACKGROUND
While Molnupiravir and Paxlovid have recently been approved for use in some countries, there are no widely available treatments for COVID-19, the disease caused by SARS-CoV-2 infection. Herbal extracts have been used to treat respiratory clinical indications by Ayurvedic medicine practitioners with minimal adverse reactions and intense research efforts are currently under way to develop some of these formulations for COVID-19 treatment.
METHODS
METHODS
Literature search for
RESULTS
RESULTS
The search yielded 20 peer reviewed articles on
CONCLUSION
CONCLUSIONS
The most commonly used Ayurvedic treatments for management of respiratory symptoms associated with SARS-CoV-2 infection appear to have prophylactic and/or therapeutic properties. It would be of particular interest to assess synergistic and concomitant systemic effects and antiviral activities of individual phytoconstituents and their combinations in the Ayurvedic treatments.
Identifiants
pubmed: 35474908
doi: 10.1016/j.phyplu.2022.100286
pii: S2667-0313(22)00069-0
pmc: PMC9020642
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100286Informations de copyright
© 2022 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMJ. 2021 Apr 26;373:n949
pubmed: 33903131
J Herb Med. 2021 Oct;29:100472
pubmed: 34055580
Phytochem Anal. 2021 Jul;32(4):629-639
pubmed: 33167083
J Pharm Bioallied Sci. 2021 Apr-Jun;13(2):256-267
pubmed: 34349488
Front Pharmacol. 2021 May 28;12:669362
pubmed: 34122090
Phytother Res. 2020 Dec;34(12):3411-3419
pubmed: 32748969
Drug Resist Updat. 2021 Dec;59:100794
pubmed: 34991982
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100324
pubmed: 32527713
J Biomol Struct Dyn. 2021 Aug;39(12):4304-4315
pubmed: 32544024
Adv Integr Med. 2020 Dec;7(4):181-182
pubmed: 33520646
Lancet Glob Health. 2022 Jan;10(1):e42-e51
pubmed: 34717820
Int J Ayurveda Res. 2010 Apr;1(2):112-21
pubmed: 20814526
Respir Res. 2021 Apr 6;22(1):99
pubmed: 33823870
Front Pharmacol. 2021 Apr 19;12:635510
pubmed: 33953674
J Biomol Struct Dyn. 2022 Jun;40(9):3949-3964
pubmed: 33251972
Trials. 2021 Sep 15;22(1):623
pubmed: 34526104
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100325
pubmed: 33446377
Complement Ther Med. 2021 Nov;62:102768
pubmed: 34418550
Evid Based Complement Alternat Med. 2014;2014:925069
pubmed: 24795773
J Biomol Struct Dyn. 2022 Jan;40(1):1-13
pubmed: 32469279
Nat Rev Microbiol. 2021 Nov;19(11):685-700
pubmed: 34535791
Food Funct. 2021 Oct 4;12(19):8867-8881
pubmed: 34528635
Planta Med. 2011 Apr;77(6):662-71
pubmed: 21204042
Crit Rev Food Sci Nutr. 2021 Oct 6;:1-31
pubmed: 34613853
RSC Adv. 2020 Jun 19;10(39):23379-23393
pubmed: 35693131
J Biomol Struct Dyn. 2021 Jun;39(9):3092-3098
pubmed: 32329419
Front Microbiol. 2020 Feb 28;11:182
pubmed: 32256457
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Drug Des Devel Ther. 2021 Mar 11;15:1111-1133
pubmed: 33737804
Am J Physiol Lung Cell Mol Physiol. 2021 May 1;320(5):L757-L769
pubmed: 33565386
N Engl J Med. 2022 Feb 10;386(6):509-520
pubmed: 34914868
J Ayurveda Integr Med. 2022 Apr-Jun;13(2):100393
pubmed: 33897204
Comput Biol Med. 2021 Sep;136:104683
pubmed: 34329860
J Biomol Struct Dyn. 2021 Aug;39(12):4510-4521
pubmed: 32568012
J Biomol Struct Dyn. 2021 Sep;39(15):5668-5681
pubmed: 32643552
J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X211020685
pubmed: 34057365
Trials. 2020 Oct 27;21(1):892
pubmed: 33109252
J Biomol Struct Dyn. 2022 Jan;40(1):190-203
pubmed: 32851919
Front Mol Biosci. 2021 Jul 02;8:637329
pubmed: 34277698
Phytomedicine. 2021 Apr;84:153494
pubmed: 33596494
Int J Mol Sci. 2021 Feb 28;22(5):
pubmed: 33671104
J Ayurveda Integr Med. 2015 Jan-Mar;6(1):11-8
pubmed: 25878458
Eur J Integr Med. 2021 Apr;43:101268
pubmed: 33520014
Saudi J Biol Sci. 2020 Oct;27(10):2674-2682
pubmed: 32837219
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100397
pubmed: 33519133
BMJ. 2020 Jul 30;370:m2980
pubmed: 32732190
PLoS One. 2021 Jun 11;16(6):e0248479
pubmed: 34115763
J Inflamm Res. 2020 Dec 31;13:1219-1243
pubmed: 33414643
BMC Complement Altern Med. 2017 Feb 14;17(1):110
pubmed: 28196487
Trials. 2021 Aug 28;22(1):570
pubmed: 34454572
BMJ. 2021 Sep 23;374:n2231
pubmed: 34556486
Acta Pharm Sin B. 2015 Jul;5(4):310-5
pubmed: 26579460
Virusdisease. 2020 Jun;31(2):179-193
pubmed: 32656311
J Biomol Struct Dyn. 2022 Mar;40(4):1858-1908
pubmed: 33246398
Annu Rev Microbiol. 2019 Sep 8;73:529-557
pubmed: 31226023
Front Pharmacol. 2021 Jun 29;12:575877
pubmed: 34267652
Phytother Res. 2020 Dec;34(12):3420-3433
pubmed: 32969524
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Trials. 2021 Feb 11;22(1):130
pubmed: 33573696
Neuroimmunomodulation. 2020;27(2):80-86
pubmed: 33341814
Virusdisease. 2021 Sep;32(3):511-517
pubmed: 34337109
Antimicrob Agents Chemother. 2015 Feb;59(2):1088-99
pubmed: 25487801
Front Nutr. 2021 Sep 17;8:679312
pubmed: 34604272
J Biomol Struct Dyn. 2022 Mar;40(4):1719-1735
pubmed: 33073699